BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8332934)

  • 1. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.
    Gregory PE; Gutmann DH; Mitchell A; Park S; Boguski M; Jacks T; Wood DL; Jove R; Collins FS
    Somat Cell Mol Genet; 1993 May; 19(3):265-74. PubMed ID: 8332934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H; Gutmann DH
    Brain Res; 1997 Jun; 759(1):149-52. PubMed ID: 9219873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity.
    Bollag G; McCormick F; Clark R
    EMBO J; 1993 May; 12(5):1923-7. PubMed ID: 8491185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
    Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the neurofibromatosis type 1 gene product.
    Gutmann DH; Wood DL; Collins FS
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9658-62. PubMed ID: 1946382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
    EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the neurofibromatosis type 1 protein product.
    DeClue JE; Cohen BD; Lowy DR
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic properties, tissue and intracellular distribution of neurofibromin.
    Golubić M; Roudebush M; Dobrowolski S; Wolfman A; Stacey DW
    Oncogene; 1992 Nov; 7(11):2151-9. PubMed ID: 1437143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
    Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
    Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.
    Marchuk DA; Saulino AM; Tavakkol R; Swaroop M; Wallace MR; Andersen LB; Mitchell AL; Gutmann DH; Boguski M; Collins FS
    Genomics; 1991 Dec; 11(4):931-40. PubMed ID: 1783401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin.
    Ahmadian MR; Wiesmüller L; Lautwein A; Bischoff FR; Wittinghofer A
    J Biol Chem; 1996 Jul; 271(27):16409-15. PubMed ID: 8663212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP.
    Boyer MJ; Gutmann DH; Collins FS; Bar-Sagi D
    Oncogene; 1994 Feb; 9(2):349-57. PubMed ID: 8290249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromin: a general outlook.
    Trovó-Marqui AB; Tajara EH
    Clin Genet; 2006 Jul; 70(1):1-13. PubMed ID: 16813595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
    Nakafuku M; Nagamine M; Ohtoshi A; Tanaka K; Toh-e A; Kaziro Y
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6706-10. PubMed ID: 8341688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues.
    Gutmann DH; Geist RT; Rose K; Wright DE
    Dev Dyn; 1995 Mar; 202(3):302-11. PubMed ID: 7780179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
    Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein.
    Suzuki H; Takahashi K; Kubota Y; Shibahara S
    Biochem Biophys Res Commun; 1992 Sep; 187(2):984-90. PubMed ID: 1339276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
    Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
    Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.